Skip to main content
. 2017 Oct 18;7(5):287–295. doi: 10.1080/20009666.2017.1379845

Table 1.

Patient characteristics.

Characteristic Control N = 41 Intervention N = 40 Total N = 81 p-value
Age, years 58.6 (19.5) 61.4 (20.6) 60.0 (20.0) 0.537
Female 14 (34.1) 17 (42.5) 31 (38.3) 0.439
Total number of comorbidities 2.7 (1.6) 3.1 (1.3) 2.9 (1.4) 0.285
Comorbidities        
Alcohol or recreational drug use 11 (26.8) 11 (27.5) 22 (27.2) 0.946
 Depression 8 (19.5) 8 (20.0) 16 (19.8) 0.956
 Insomnia or chronic outpatient sleep aid use 1 (2.4) 2 (5.0) 3 (3.7) 0.542
 Rheumatologic 3 (7.3) 5 (12.5) 8 (9.9) 0.434
 Pulmonary 7 (17.1) 15 (37.5) 22 (27.2) 0.039
 GI 12 (29.3) 12 (30.0) 24 (29.6) 0.943
 Endocrine 16 (39.0) 22 (55.0) 38 (46.9) 0.150
 Cardiovascular 22 (53.7) 20 (50.0) 42 (51.9) 0.742
 Cancer 12 (29.3) 6 (15.0) 18 (22.2) 0.123
Shift work in past year 15 (36.6) 5 (12.5) 20 (24.7) 0.012
Self-reported previous diagnosis of sleep disorder 7 (17.1) 14 (35.0) 21 (25.9) 0.066
Sleep pharmaceutic use at home in past year 19 (46.3) 19 (47.5) 38 (46.9) 0.917
Any sleep pharmaceutic use in hospital 12 (29.3) 12 (30.0) 24 (29.6) 0.943
Single patient room 7 (17.1) 8 (20.0) 15 (18.5) 0.735
Frequency of scheduled vitals       0.438
 < 4x/day 13 (31.7) 19 (47.5) 32 (39.5)  
 ≥ 4x/day 28 (68.3) 21 (52.5) 49 (60.5)  
Length of stay, days 5.8 (3.9) 6.8 (5.6) 6.3 (4.8) 0.378
Any exposure to ICU/CCU 3 (7.3) 4 (10.0) 7 (8.6) 0.668
Most responsible diagnosis        
 DM 2 (4.9) 0 (0.0) 2 (2.5) 0.132
 Delirium 1 (2.4) 2 (5.0) 3 (3.7)  
 HF 3 (7.3) 5 (12.5) 8 (9.9)  
 Infection 14 (34.1) 17 (42.5) 31 (38.3)  
 Substance 9 (22.0) 4 (10.0) 13 (16.0)  
 VTE 4 (9.8) 0 (0.0) 4 (4.9)  
 Other 8 (19.5) 12 (30.0) 20 (24.7)  

Numbers are displayed as n (%) for categorical variables and mean (SD) for continuous variables. p-values calculated using Chi-square test (categorical) or t-test (continuous)